RaySearch Laboratories AB (publ) Interim Report January 1 - June 30, 2008

RaySearch Laboratories AB (publ) Interim Report January 1 - June 30, 2008

JANUARY 1 - JUNE 30, 2008 
•  Net sales for the period amounted to SEK 27.6 M (33.5) 

•  Profit after tax was SEK 4.2 M (10.7) 

•  Earnings per share amounted to SEK 0.12 (0.31)

•  Operating profit amounted to SEK 4.4 M (14.3)

•  Cash flow from operating activities amounted to SEK 5.4 M (19.8)

•  Agreement with Philips regarding a new product for the new revolutionary
treatment method VMAT. 


AFTER THE END OF THE REPORTING PERIOD
•  Agreement with Uppsala University Hospital regarding treatment planning
system for proton therapy 

•  Agreement covering research cooperation within multi-criteria optimization
with Massachusetts General Hospital in Boston, USA.



”We are far from satisfied with this profit level, but we strongly believe that
the actions we have taken to strengthen sales of the released products will
improve the situation. In addition, there are several new product releases
scheduled in the coming year,” says Johan Löf, President of RaySearch.

”RaySearch's guiding principle is to shorten the time required for new
scientific discoveries to reach clinical application. Within the framework of
our current business model we have several times experienced delays that are
beyond RaySearch's control. We have therefore started evaluating the possibility
of selling direct to clinics in parallel with sales through our partners,”
concludes Johan Löf.





FOR FURTHER INFORMATION, PLEASE CONTACT:

Johan Löf, President and CEO
Tel: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com

RaySearch Laboratories AB (publ)
Corp. Org. No: 556322-6157
Sveavägen 25
SE-111 34 Stockholm 
Sweden

ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch's
products are sold through license agreements with leading partners such as
Philips, Varian, Nucletron, IBA Dosimetry and TomoTherapy. Eight products have
been released to date and RaySearch's software is used at over 1,300 clinics in
more than 30 countries. In addition, existing license agreements cover more than
15 other products that are scheduled to be launched in the coming years.
RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in
Stockholm and the company is listed in the SmallCap segment on the OMX Nordic
Exchange Stockholm. 

For more information about RaySearch, visit www.raysearchlabs.com.